1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Atlas Arteria Limited
  6. News
  7. Summary
    ALX   AU0000013559

ATLAS ARTERIA LIMITED

(ALX)
  Report
Delayed Australian Stock Exchange  -  05/25 02:10:51 am EDT
7.030 AUD   +1.01%
05/24Atlas Arteria's 31.14%-Owned APRR Prices $533 Million of Euro Bonds
MT
05/09TRANSCRIPT : Atlas Arteria Limited - Shareholder/Analyst Call
CI
04/26ATLAS ARTERIA : Ceasing to be a substantial holder from MQG
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Atlas Arteria : 2021 Investor Day

11/16/2021 | 04:47pm EDT

For personal use only

17 November 2021

ASX RELEASE

Atlas Arteria 2021 Investor Day

Atlas Arteria (ASX:ALX) attaches the slides that will support the presentation to be provided at the Atlas Arteria Investor Day today.

The Investor Day will be a live video webcast at 9:00am Australian Eastern Daylight Time and accessible from the Atlas Arteria website:

www.atlasarteria.com/investor-centre

To participate in the Investor Day, pre-registration is required via the following link.

____________________________________________________________________________________

For further information please contact:

Investors:

Media:

Jeanette Royce

Lisa Keenan

Director, Investor Relations

Nightingale Advisors

1800 621 694 / +61 (0) 438 493 692

+61 (0) 409 150 771

investors@atlasarteria.com

lisa@nightingaleadvisors.com.au

____________________________________________________________________________________

This announcement has been authorised for release by Clayton McCormack, General Counsel and Company Secretary.

About Atlas Arteria

Atlas Arteria (ASX:ALX) is a global owner, operator and developer of toll roads, creating value for our investors over the long-term through considered and disciplined management. The roads we own, operate and develop benefit communities through reduced travel time, greater time certainty, reduced fuel consumption and carbon emissions.

Today the Atlas Arteria Group consists of four businesses. We currently own a 31.14% interest in the APRR toll road group in France. Adjacent to the APRR business is the smaller ADELAC business which connects to APRR in south-east France. Together APRR and ADELAC comprise a 2,318km motorway network located in the East and South East of France. In the US, we have 100% of the economic interest in the Dulles Greenway, a 22km toll road in the Commonwealth of Virginia. In Germany, we own 100% of the Warnow Tunnel in the north-east city of Rostock.

www.atlasarteria.com

Atlas Arteria Limited

Atlas Arteria International Limited

ACN 141 075 201

EC43828

Level 5, 141 Flinders Lane, MELBOURNE 3000

4th Floor, Cedar House, 41 Cedar Avenue

Hamilton HM12 BERMUDA

onlyATLAS ARTERIA 2021 INVESTOR DAY

usenal17 November 2021

IMPORTANT INFORMATION

Disclaimer

The information in this presentation is given in good faith and derived from sources believed to be accurate at this date but onlyno representation or warranty of accuracy, completeness or

reliability is given and no responsibility or liability arising in any other way, including for errors or omission, is accepted by At as Arteria or its officers. The material contained in this presentation may include information derived from publicly available sources that have not been independently verified.

This presentation is not an offer or invitation for subscription r purchase of, or a recommendation of, securities. It does

n t take into account the investment objectives, financial situation and particular needs of the investor. Information in this presentation should not be considered as advice or a recommendation to investors or potential investors. Before making an investment in Atlas Arteria, the investor

useor prospective investor should consider whether such an inv stment is appropriate to their particular investment n ds, objectives and financial circumstances and consult an investment adviser if appropriate.

Inve tments in Atlas Arteria are subject to investment risk, including possible delays in repayment and loss of income and capital invested.

Forward Looking Statements

This presentation may contain forward-looking statements including statements with respect to Atlas Arteria's future performance. Due care and attention have been exercised in the preparation of forward-looking statements, however actual results may vary as a result of various factors.

Non-IFRS Information

This presentation includes certain financial measures that are not recognised under Australian Accounting Standards (AAS) or International Financial Reporting Standards (IFRS). Such non-IFRS financial measures do not have a standardised meaning prescribed by AAS or IFRS and may not be comparable to similarly titled measures presented by other entities, and should not be construed as an alternative to other financial measures determined in accordance with AAS or IFRS. Recipients are cautioned not to place undue reliance on any non-IFRS financial measures included in this presentation. The non-IFRS information has not been subject to audit or review by the Company's external auditor.

No Offer

This presentation does not constitute an offer to sell, or the solicitation of an offer to buy, any securities in the United States or any other jurisdiction. Atlas Arteria's securities have not been, and will not be, registered under the US Securities Act of 1933, as amended (US Securities Act) or the securities laws of any state or other jurisdiction of the United States or elsewhere. Accordingly, Atlas Arteria's securities may not be offered or sold, directly or indirectly, in the United States unless they are offered or sold pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and any other applicable US state securities laws.

U.S. Ownership Restrictions

Atlas Arteria's securities are subject to ownership restrictions that apply to residents of the United States and other US persons who are not "qualified purchasers" (as defined in Section 2(a)(51) of the US Investment Company Act of 1940). For further details, please see our website https://atlasarteria.com/stores/_sharedfiles/US_ Ownership/AtlasArteria-USownershiprestrictions.pdf

nal

Atlas Arteria > 2021 Investor Day > 2

AGENDA

CEO WELCOME & GROUP STRATEGY

Graeme Bevans, CEO at Atlas Arteria

ECONOMIC UPDATE

onlyJean-François Robin, Global Head of Research, Corporate & Investment Banking at Natixis

TRAFFIC UPDATE

Ryan Reynolds, Director Forecasting

and Analysis at Atlas Arteria

APRR

useVincent Portal-Barrault, COO at Atlas Arteria Jean-GeorgesMalcor, Non-Executive Director of Atlas Arteria

nal

DULLES GREENWAY

Renée Hamilton, CEO at Dulles Greenway Pierce Homer, Director of Dulles Greenway

James Lerner, Director US Operations at Atlas Arteria

WARNOW TUNNEL

Yvonne Osterkamp, Managing Director at Warnow Tunnel

FINANCIAL UPDATE

Nadine Lennie, CFO at Atlas Arteria

CLOSING Q&A

Atlas Arteria > 2021 Investor Day > 3

CEO WELCOME

& GROUP STRATEGY

only

Graeme

use

Bevans

Chief Executive Officer

& Managing Director

of ATLAX

nal

Atlas Arteria > 2021 Investor Day > 4

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Atlas Arteria Group published this content on 16 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 November 2021 21:46:12 UTC.


© Publicnow 2021
All news about ATLAS ARTERIA LIMITED
05/24Atlas Arteria's 31.14%-Owned APRR Prices $533 Million of Euro Bonds
MT
05/09TRANSCRIPT : Atlas Arteria Limited - Shareholder/Analyst Call
CI
04/26ATLAS ARTERIA : Ceasing to be a substantial holder from MQG
PU
04/21UBS Adjusts Atlas Arteria's Price Target to AU$6.53 From AU$6.58, Keeps at Neutral
MT
04/19Atlas Arteria Limited Reports Toll Revenue Results for the March Quarter 2022
CI
04/19Atlas Arteria Limited Reports Traffic Results for the March Quarter 2022
CI
04/11ATLAS ARTERIA : Becoming a substantial holder from MQG
PU
04/08ATLAS ARTERIA : Becoming a substantial holder from MQG
PU
04/07Atlas Arteria Appoints CFO
MT
04/07Atlas Arteria Limited Announces Executive Changes
CI
More news
Analyst Recommendations on ATLAS ARTERIA LIMITED
More recommendations
Financials
Sales 2022 132 M 93,1 M 93,1 M
Net income 2022 384 M 272 M 272 M
Net Debt 2022 1 406 M 995 M 995 M
P/E ratio 2022 17,5x
Yield 2022 5,91%
Capitalization 6 742 M 4 770 M 4 770 M
EV / Sales 2022 62,0x
EV / Sales 2023 54,6x
Nbr of Employees -
Free-Float 93,2%
Chart ATLAS ARTERIA LIMITED
Duration : Period :
Atlas Arteria Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ATLAS ARTERIA LIMITED
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Last Close Price 7,03 AUD
Average target price 6,77 AUD
Spread / Average Target -3,69%
EPS Revisions
Managers and Directors
Graeme Frances Bevans Chief Executive Officer & Director
David Collins Chief Financial Officer
Debra L. Goodin Independent Non-Executive Chairman
Vincent Portal-Barrault Chief Operating Officer
David Bartholomew Independent Non-Executive Director